PERPHENAZIN HCL

Pernidazole is a nitroimidazole derivative that is activated under anaerobic conditions to damage DNA in susceptible protozoa and bacteria. It has been used in parasitic infections. Side effects include metallic taste, nausea, headache, dizziness, and potential neurotoxicity or peripheral neuropathy with prolonged use, similar to related nitroimidazoles. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 432a54b9fd5a Category: Tag:

Product Description


Mechanism of Action

PERPHENAZIN HCL demonstrates a multidimensional biochemical activity pattern, affecting enzymeregulated catalytic networks, receptormediated intracellular signalling, mitochondrial respiratory pathways, oxidativestress regulation, ionchannel behaviour, cytoskeletal mechanics and transcriptionfactor network modulation. Structural evidence suggests potential interactions with catalytic residues, allosteric domains, transmembrane protein complexes, regulatory scaffolds and intracellular signalling intermediates. These interactions allow PERPHENAZIN HCL to influence phosphorylation kinetics, secondmessenger signalling (Ca²⁺, cAMP, IP, DAG), redoxbuffering systems, ATP turnover rates and mitochondrial membranepotential stability.

Depending on experimental conditions, PERPHENAZIN HCL may alter metabolic flux distribution, cytoskeletal tension, vesicular transport efficiency, chromatinaccessibility patterns and geneexpression networks related to stress responses, inflammation, apoptosis, autophagy and metabolic adaptation.

Benefits and Advantages

This compound is widely used across highresolution biochemical and pharmacological research areas, including:

  • Receptorligand interaction analysis and affinitymapping
  • Detailed enzymekinetics profiling and catalyticpathway evaluation
  • Mitochondrialdynamics studies, ATPflux modelling and oxidativestress research
  • Integrated multiomics applications (transcriptomics, metabolomics, proteomics, phosphoproteomics)
  • Cytoskeletal and membranemechanics modelling
  • Apoptosis, necroptosis, ferroptosis and autophagy signalling pathway studies
  • SAR (structureactivity relationship) and molecularoptimisation pipelines
  • Mechanistic pharmacodynamic modelling and thresholdactivation experiments

Side Effects and Risks

Laboratoryobserved risks include:

  • Oxidativestress imbalance and ROS overproduction
  • Mitochondrial overload or suppression of respiratorychain complexes
  • Dysregulation of Na⁺/K⁺/Ca²⁺ transport and ionchannel behaviour
  • Unintended receptor crosstalk or inhibitory interference
  • Cytoskeletal destabilisation and membrane-integrity compromise
  • Dosedependent cytotoxicity leading to apoptosis or autophagy
  • Transcriptional instability or inflammatory signalling activation (NF-κB, JNK, MAPK)

Use exclusively under controlled laboratory conditions with strict biosafety procedures.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C21H26ClN3O·HCl

Molecular Weight

390.91 g/mol

CAS Number

58-39-9

Storage Condition

Store at 2-8°C

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

perphenazine; 58-39-9; Trilafon; Perphenazin; Perfenazine

IUPAC/Chemical Name

2-chloro-10-(3-dimethylaminopropyl)phenothiazine hydrochloride

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download